Novocure LUNAR EF-24

To test the efficacy and safety of TTFields, using the NovoTTF-100L System, concurrent with standard therapies for stage 4 NSCLC patients, following progression while/on/after platinum based treatment

Topic

Novocure LUNAR EF-24

Description

LUNAR: Pivotal, randomized, open-label study of Tumor Treating Fields (TTFields) concurrent with standard of care therapies for treatment of stage 4 non-small cell lung cancer (NSCLC) following platinum failure

Physicians

Contact

Florida East Coast-Jacksonville

Maddie Hamilton